MABLYTICS Trademark

Trademark Overview

On Friday, January 28, 2022, a trademark application was filed for MABLYTICS with the United States Patent and Trademark Office. The USPTO has given the MABLYTICS trademark a serial number of 97243612. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by MABLYTICS, INC.. The MABLYTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields related to antibodies
mablytics

General Information

Serial Number97243612
Word MarkMABLYTICS
Filing DateFriday, January 28, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Description of MarkThe mark consists of a chevron design which is pointing at the word "MABLYTICS".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields related to antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMABLYTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameMABLYTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 1 GRANTED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022ASSIGNED TO EXAMINER
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 2, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022NEW APPLICATION ENTERED

Related Keywords

mablytics related antibodies fields biotechnology development pharmaceutical research